Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Polynovo Ltd (PNV.AX)

Polynovo Ltd (PNV.AX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Polynovo Ltd 320 Lorimer Street Unit 2 Port Melbourne VIC 3207 AUS

https://www.polynovo.com P: +61 386814050 F: +61 386814099

Description:

Polynovo earns most of its revenue from US sales of its NovoSorb Biodegradable Temporizing Matrix, or NovoSorb BTM. The product is a patented biodegradable synthetic scaffold to support the regeneration of the dermis when lost through surgery, trauma, burns, or other causes of tissue loss. Once the product is applied to a wound, it takes a few weeks for the dermal layer to fully integrate within the polymer scaffold before a clinician can delaminate the outer layer. A small wound would then close either naturally or with a dressing, while a larger wound would close through a split-skin graft or alternative product such as Avita's RECELL. NovoSorb BTM then slowly degrades to harmless byproducts which are fully absorbed in roughly 18 months.

Key Statistics

Overview:

Market Capitalization, $K 1,373,563
Shares Outstanding, K 690,233
Annual Sales, $ 65,241 K
Annual Net Income, $ -4,925 K
% of Institutional Shareholders 15.36%

Growth:

1-Year Return 25.77%
3-Year Return -33.67%
5-Year Return 86.85%
5-Year Revenue Growth 62.75%

Per-Share Information:

Latest Earnings Date N/A
Earnings Per Share ttm 0.00
Dividend Payout Ratio 0.00%
Most Recent Split 0-1 on 05/03/04

PNV.AX Ratios

Ratio
Price/Earnings ttm 796.00
Price/Earnings forward 131.58
Return-on-Equity % 2.42%
Return-on-Assets % 1.71%
Profit Margin % -7.55%
Debt/Equity 0.22
Price/Sales 16.72
Price/Book 19.89
Book Value/Share 0.10
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar